Male-female differences in transitions from first drug opportunity to first use: searching for subgroup variation by age, race, region, and urban status
- PMID: 11703892
- DOI: 10.1089/15246090152636550
Male-female differences in transitions from first drug opportunity to first use: searching for subgroup variation by age, race, region, and urban status
Abstract
Recent studies in the United States suggest that male-female differences in the prevalence of drug use may result from sex differences in opportunities to use drugs rather than from differences in the likelihood of making a transition into drug use once an opportunity has occurred. That is, men have more opportunities to try drugs, but women appear to be just as likely as men to initiate drug use when given the opportunity to do so. This paper examines whether this general observation holds for subgroups defined by age or birth cohort, race/ethnicity, geographic region, and urban status. We analyzed data from the 1991, 1992, and 1993 National Household Surveys on Drug Abuse. We found general consistency across the subgroups studied. Males were more likely than females to have opportunities to use drugs, but the sexes were equally likely to make a transition into drug use once an opportunity had occurred to try a drug. The implications of this evidence are discussed in relation to the epidemiology and prevention of drug use and with respect to future research on sex and gender differences in drug involvement.
Similar articles
-
Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin.Drug Alcohol Depend. 1999 Apr 1;54(2):117-25. doi: 10.1016/s0376-8716(98)00151-3. Drug Alcohol Depend. 1999. PMID: 10217551
-
Male-female differences in the earliest stages of drug involvement.Addiction. 1999 Sep;94(9):1413-9. doi: 10.1046/j.1360-0443.1999.949141312.x. Addiction. 1999. PMID: 10615725
-
First opportunities to try drugs and the transition to first drug use: evidence from a national school survey in Panama.Subst Use Misuse. 1999 Aug;34(10):1451-67. doi: 10.3109/10826089909029392. Subst Use Misuse. 1999. PMID: 10446769
-
Regional variation in drug purchase opportunity among youths in the United States, 1996-1997.J Urban Health. 2002 Mar;79(1):104-12. doi: 10.1093/jurban/79.1.104. J Urban Health. 2002. PMID: 11937619 Free PMC article.
-
The social demography of drug use.Milbank Q. 1991;69(3):365-414. Milbank Q. 1991. PMID: 1805113 Review.
Cited by
-
Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.Molecules. 2023 Jul 7;28(13):5270. doi: 10.3390/molecules28135270. Molecules. 2023. PMID: 37446929 Free PMC article. Review.
-
Oxycodone: A Current Perspective on Its Pharmacology, Abuse, and Pharmacotherapeutic Developments.Pharmacol Rev. 2023 Nov;75(6):1062-1118. doi: 10.1124/pharmrev.121.000506. Epub 2023 Jun 15. Pharmacol Rev. 2023. PMID: 37321860 Review.
-
Mental health symptoms among homeless shelter residents during COVID-19 lockdown in Tshwane, South Africa.Afr J Prim Health Care Fam Med. 2023 Apr 3;15(1):e1-e8. doi: 10.4102/phcfm.v15i1.3730. Afr J Prim Health Care Fam Med. 2023. PMID: 37042538 Free PMC article.
-
Estimating the prevalence of high-risk behaviors using network scale-up method in medical university students.J Educ Health Promot. 2022 Nov 26;11:356. doi: 10.4103/jehp.jehp_920_21. eCollection 2022. J Educ Health Promot. 2022. PMID: 36618457 Free PMC article.
-
Harmful Alcohol Use Among Healthcare Workers at the Beginning of the COVID-19 Pandemic in Kenya.Front Psychiatry. 2022 Feb 28;13:821610. doi: 10.3389/fpsyt.2022.821610. eCollection 2022. Front Psychiatry. 2022. PMID: 35295779 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
